Once Burned, Twice Shy? Pharma Urged To Engage On Entitlement Reform
Executive Summary
Despite the current challenges to the ACA, the biopharmaceutical industry should engage proactively with lawmakers as Medicare and Medicaid face major reforms in the coming years, health policy experts urge at PhRMA’s annual meeting.
You may also be interested in...
Improved Adherence To Diabetes Drugs Can Lower Hospitalizations 13%, Study Finds
Researchers at Harvard and Express Scripts estimate that improved adherence to diabetes drugs could save nearly $5 billion annually across the U.S. health care system.
Reimbursement News, In Brief
Only 11% of physicians plan to apply for EHR federal incentives and appeared about to meet about two-thirds of “meaningful use” requirements, Health Affairs analysis finds; Part D expenditures are increasing by almost 9% annually and rebates are about 11%.
Voices From The Bench: Supreme Court Justices Probe The Affordable Care Act
“The Pink Sheet” highlights intriguing, and perhaps telling, comments by U.S. Supreme Court justices from three days of oral arguments pertaining to the constitutionality of the Affordable Care Act, including the constitutionality of the “individual mandate” for insurance coverage, its severability from other ACA provisions, and whether new Medicaid requirements are an unconstitutional coercion of the states.